Search

Your search keyword '"Donkervoort, Sandra"' showing total 651 results

Search Constraints

Start Over You searched for: Author "Donkervoort, Sandra" Remove constraint Author: "Donkervoort, Sandra"
651 results on '"Donkervoort, Sandra"'

Search Results

1. Cost-effectiveness of general practitioner- versus surgeon-led colon cancer survivorship care: an economic evaluation alongside a randomised controlled trial

2. Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy.

3. SNUPN deficiency causes a recessive muscular dystrophy due to RNA mis-splicing and ECM dysregulation

4. Digenic inheritance involving a muscle-specific protein kinase and the giant titin protein causes a skeletal muscle myopathy

5. CIAO1 loss of function causes a neuromuscular disorder with compromise of nucleocytoplasmic Fe-S enzymes

6. Unraveling factors associated with textbook outcome after cholecystectomy in patients with uncomplicated cholecystolithiasis: A posthoc analysis of individual data of 1,124 patients

7. Exome copy number variant detection, analysis, and classification in a large cohort of families with undiagnosed rare genetic disease

9. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

11. Variants in DTNA cause a mild, dominantly inherited muscular dystrophy

12. International retrospective natural history study of LMNA-related congenital muscular dystrophy

13. International retrospective natural history study of LMNA-related congenital muscular dystrophy.

14. Persistent and new-onset symptoms after cholecystectomy in patients with uncomplicated symptomatic cholecystolithiasis: A post hoc analysis of 2 prospective clinical trials

15. The expanding clinical and genetic spectrum of DYNC1H1-related disorders

16. Genome Sequencing for Diagnosing Rare Diseases

17. Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related Dystrophy

18. Effects of HMGCR deficiency on skeletal muscle development

19. Unraveling factors associated with textbook outcome after cholecystectomy in patients with uncomplicated cholecystolithiasis: A posthoc analysis of individual data of 1,124 patients

21. Adult MTM1-related myopathy carriers: Classification based on deep phenotyping.

22. Heterozygous frameshift variants in HNRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy

23. A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene.

25. Childhood Onset Amyotrophic Lateral Sclerosis Associated with SPTLC2 Gain-of-Function Pathogenic Variants: Clinical, Genetic, and Biochemical Insights (P4-8.001)

26. Pathogenic TNNI1 variants disrupt sarcomere contractility resulting in hypo- and hypercontractile muscle disease

27. The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy

28. Differential inclusion of NEB exons 143 and 144 provides insight into NEB-related myopathy variant interpretation and disease manifestation

29. Detecting missed diagnoses of spinal muscular atrophy in genome, exome, and panel sequencing datasets

30. Clinical, immunohistochemical and genetic characterization of splice-altering biallelic DES variants: therapeutic implications

31. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis

32. Loss of Function of the Cytoplasmic Fe-S Assembly Protein CIAO1 Causes a Neuromuscular Disorder with Compromise of Nucleocytoplasmic Fe-S Enzymes

33. Recurrentde-novo gain-of-functionmutation inSPTLC2confirms dysregulated sphingolipid production to cause juvenile amyotrophic lateral sclerosis

34. Recurrent de novoSPTLC2variant causes childhood-onset amyotrophic lateral sclerosis (ALS) by excess sphingolipid synthesis

35. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

36. Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder

37. Innocuous pressure sensation requires A-type afferents but not functional ΡΙΕΖΟ2 channels in humans

39. Cross-sectional Neuromuscular Phenotyping Study of Patients With Arhinia With SMCHD1 Variants

40. Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia.

41. Clinical, Pathologic, and Mutational Spectrum of Dystroglycanopathy Caused by LARGE Mutations

42. A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome.

43. Frequency of Prader-Willi syndrome in births conceived via assisted reproductive technology.

44. Recurrent de-novo gain-of-function mutation in SPTLC2 confirms dysregulated sphingolipid production to cause juvenile amyotrophic lateral sclerosis.

45. Recurrent de novo SPTLC2 variant causes childhoodonset amyotrophic lateral sclerosis (ALS) by excess sphingolipid synthesis.

46. Biallelic variants inHMGCS1are a novel cause of rare rigid spine syndrome

47. Exome copy number variant detection, analysis and classification in a large cohort of families with undiagnosed rare genetic disease

48. Persistent and new-onset symptoms after cholecystectomy in patients with uncomplicated symptomatic cholecystolithiasis: A post hoc analysis of 2 prospective clinical trials

50. Unique Capabilities of Genome Sequencing for Rare Disease Diagnosis

Catalog

Books, media, physical & digital resources